Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028 Meeting Abstract
| Authors: | Burgess, M. A.; Roszik, J.; Van Tine, B. A.; Hu, J.; Schuetze, S.; D'Angelo, S. P.; Attia, S.; Priebat, D. A.; Okuno, S. H.; Riedel, R. F.; Davis, L. E.; Movva, S.; Reed, D. R.; Baker, L. H.; Reinke, D. K.; Maki, R. G.; Patel, S.; Tawbi, H. A. H.; Butterfield, L. H. |
| Abstract Title: | Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028 |
| Meeting Title: | 2017 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2017 Feb 23-25 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-03-01 |
| Language: | English |
| ACCESSION: | WOS:000443282900057 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2017.35.7_suppl.60 |
| Notes: | Meeting Abstract: 60 -- Source: Wos |
